Rating Change
UBS analysts initiated coverage on STERIS plc (NYSE:STE) with a Buy rating on July 28, 2026.
new coverageNYSE:STE
UBS Initiates Coverage on STERIS plc (STE) with Buy
Rating Change UBS analysts initiated coverage on STERIS plc (NYSE:STE) with a Buy rating on July 28, 2026. Market Context STERIS plc operates in the Healthcare sector. The stock…
Market Context
STERIS plc operates in the Healthcare sector. The stock currently trades at $230.34 with a market capitalization of $24.8B. The stock has declined 15.5% over the past 52 weeks.
Analyst coverage from UBS provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for STERIS plc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for STERIS plc
Among the 10 most recent ratings: 7 Buy, 3 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 28, 2026 | UBS | Buy | N/A |
| May 13, 2026 | Keybanc | Overweight | N/A |
| Jul 22, 2025 | Keybanc | Overweight | N/A |
| Jul 15, 2025 | Morgan Stanley | Overweight | N/A |
| May 29, 2025 | Jefferies | Hold | N/A |
Related Tools: Analyst Ratings Dashboard | View STE Stock Page
Frequently Asked Questions
What does a Buy rating mean for STE?
A Buy rating from UBS reflects the analyst's outlook on STERIS plc (NYSE:STE). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the STE forecast page.
